20 results
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws
6-K
EX-1.1
krsgbljfn454k3 99dt1
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-99.1
f3r es5ra
3 Feb 21
Current Report
7:55am
6-K
EX-99.1
1s0000k
3 Dec 20
Enlivex Reports Positive Interim Results From Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
8:00am
6-K
EX-99.1
sey6dvyfclis cv68wcr
27 Oct 20
Report of Foreign Private Issuer
8:03am
6-K
EX-99.1
yzpr0rlxcfpn2pj0
22 Oct 20
Enlivex Reports Dosing of First Two Patients in Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
8:49am
6-K
EX-10.1
da66t6
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-99.1
ezouh3 zcd
13 Oct 20
Report of Foreign Private Issuer
9:30am
6-K
EX-99.1
o33l760j8tvn e6lap1s
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-1.1
b34n085f
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
l9w7sf
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-99.2
n5jm2ob86pn657rt0
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
k1s2oo5p11nch
19 Nov 18
Agreement and Plan of Merger
4:34pm
- Prev
- 1
- Next